Trial Counsel in Oxymorphone Litigation

May 2018 and 2019

Endo and Mallinckrodt v. Amneal Pharms. LLC (D. Del.); Endo and Gruenenthal v. Amneal Pharms. LLC (S.D.N.Y.)

Robins Kaplan LLP served as lead trial counsel to Amneal in Hatch-Waxman patent litigation in the District of Delaware and the Southern District of New York brought by plaintiffs, asserting infringement of a patent claiming a form of oxymorphone. While on appeal, the FDA made Endo withdraw its oxymorphone product from the market and the case ultimately settled.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Similar Results

Back to Top